APO Research
Talk to an analyst

APO RESEARCH · REPORT

Intramuscular Immune Globulin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Intramuscular Immune Globulin Industry Growth and Trends Forecast to 2032

22 December 202594 pages

Choose your research edition.

Industry ResearchIntramuscular Immune Globulin Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Intramuscular Immune Globulin Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Intramuscular Immune Globulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intramuscular Immune Globulin Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Intramuscular Immune Globulin Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Intramuscular Immune Globulin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Intramuscular Immune Globulin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Intramuscular Immune Globulin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Intramuscular Immune Globulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Intramuscular Immune Globulin include Buyer Bargaining Power, Competitive Rivalry, Supplier Bargaining Power, Threat of New Entry and Threat of Substitution, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Intramuscular Immune Globulin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Intramuscular Immune Globulin market size, estimates, and forecasts are presented in terms of sales volume (k tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Intramuscular Immune Globulin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Intramuscular Immune Globulin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Intramuscular Immune Globulin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Intramuscular Immune Globulin Market by Company

Buyer Bargaining Power

Competitive Rivalry

Supplier Bargaining Power

Threat of New Entry

Threat of Substitution

Intramuscular Immune Globulin Segment by Type

10mL Vial

2.0mL Vial

Intramuscular Immune Globulin Segment by Application

Hepatitis A

Measles

Others

Intramuscular Immune Globulin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intramuscular Immune Globulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intramuscular Immune Globulin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intramuscular Immune Globulin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Intramuscular Immune Globulin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Intramuscular Immune Globulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 10mL Vial Table 2. Major Company of 2.0mL Vial Table 3. Global Intramuscular Immune Globulin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Intramuscular Immune Globulin Sales by Type (2021-2026) & (k tons) Table 5. Global Intramuscular Immune Globulin Sales Market Share in Volume by Type (2021-2026) Table 6. Global Intramuscular Immune Globulin Sales by Type (2021-2026) & (US$ Million) Table 7. Global Intramuscular Immune Globulin Sales Market Share in Value by Type (2021-2026) Table 8. Global Intramuscular Immune Globulin Price by Type (2021-2026) & (US$/ton) Table 9. Global Intramuscular Immune Globulin Sales by Type (2027-2032) & (k tons) Table 10. Global Intramuscular Immune Globulin Sales Market Share in Volume by Type (2027-2032) Table 11. Global Intramuscular Immune Globulin Sales by Type (2027-2032) & (US$ Million) Table 12. Global Intramuscular Immune Globulin Sales Market Share in Value by Type (2027-2032) Table 13. Global Intramuscular Immune Globulin Price by Type (2027-2032) & (US$/ton) Table 14. North America Intramuscular Immune Globulin Sales by Type (2021-2026) & (k tons) Table 15. North America Intramuscular Immune Globulin Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Intramuscular Immune Globulin Sales by Type (2021-2026) & (k tons) Table 17. Europe Intramuscular Immune Globulin Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Intramuscular Immune Globulin Sales by Type (2021-2026) & (k tons) Table 19. Asia-Pacific Intramuscular Immune Globulin Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Intramuscular Immune Globulin Sales by Type (2021-2026) & (k tons) Table 21. Latin America Intramuscular Immune Globulin Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Intramuscular Immune Globulin Sales by Type (2021-2026) & (k tons) Table 23. Middle East and Africa Intramuscular Immune Globulin Sales by Type (2021-2026) & (US$ Million) Table 24. Intramuscular Immune Globulin Industry Trends Table 25. Intramuscular Immune Globulin Industry Drivers Table 26. Intramuscular Immune Globulin Industry Opportunities and Challenges Table 27. Intramuscular Immune Globulin Industry Restraints Table 28. Global Intramuscular Immune Globulin Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Intramuscular Immune Globulin Revenue Market Share by Company (2021-2026) Table 30. Global Intramuscular Immune Globulin Sales by Company (2021-2026) & (k tons) Table 31. Global Intramuscular Immune Globulin Sales Share by Company (2021-2026) Table 32. Global Intramuscular Immune Globulin Market Price by Company (2021-2026) & (US$/ton) Table 33. Global Intramuscular Immune Globulin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Intramuscular Immune Globulin Major Company Production Sites and Headquarters Table 35. Global Intramuscular Immune Globulin Company, Product Type & Application Table 36. Global Intramuscular Immune Globulin Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Intramuscular Immune Globulin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Intramuscular Immune Globulin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Intramuscular Immune Globulin Sales by Region (2021-2026) & (k tons) Table 41. Global Intramuscular Immune Globulin Sales Market Share in Volume by Region (2021-2026) Table 42. Global Intramuscular Immune Globulin Sales by Region (2021-2026) & (US$ Million) Table 43. Global Intramuscular Immune Globulin Sales Market Share in Value by Region (2021-2026) Table 44. Global Intramuscular Immune Globulin Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 45. Global Intramuscular Immune Globulin Sales by Region (2027-2032) & (k tons) Table 46. Global Intramuscular Immune Globulin Sales Market Share in Volume by Region (2027-2032) Table 47. Global Intramuscular Immune Globulin Sales by Region (2027-2032) & (US$ Million) Table 48. Global Intramuscular Immune Globulin Sales Market Share in Value by Region (2027-2032) Table 49. Global Intramuscular Immune Globulin Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2027-2032) Table 50. Global Intramuscular Immune Globulin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Intramuscular Immune Globulin Sales by Application (2021-2026) & (k tons) Table 52. Global Intramuscular Immune Globulin Sales Market Share in Volume by Application (2021-2026) Table 53. Global Intramuscular Immune Globulin Sales by Application (2021-2026) & (US$ Million) Table 54. Global Intramuscular Immune Globulin Sales Market Share in Value by Application (2021-2026) Table 55. Global Intramuscular Immune Globulin Price by Application (2021-2026) & (US$/ton) Table 56. Global Intramuscular Immune Globulin Sales by Application (2027-2032) & (k tons) Table 57. Global Intramuscular Immune Globulin Sales Market Share in Volume by Application (2027-2032) Table 58. Global Intramuscular Immune Globulin Sales by Application (2027-2032) & (US$ Million) Table 59. Global Intramuscular Immune Globulin Sales Market Share in Value by Application (2027-2032) Table 60. Global Intramuscular Immune Globulin Price by Application (2027-2032) & (US$/ton) Table 61. North America Intramuscular Immune Globulin Sales by Application (2021-2026) & (k tons) Table 62. North America Intramuscular Immune Globulin Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Intramuscular Immune Globulin Sales by Application (2021-2026) & (k tons) Table 64. Europe Intramuscular Immune Globulin Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Intramuscular Immune Globulin Sales by Application (2021-2026) & (k tons) Table 66. Asia-Pacific Intramuscular Immune Globulin Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Intramuscular Immune Globulin Sales by Application (2021-2026) & (k tons) Table 68. Latin America Intramuscular Immune Globulin Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Intramuscular Immune Globulin Sales by Application (2021-2026) & (k tons) Table 70. Middle East and Africa Intramuscular Immune Globulin Sales by Application (2021-2026) & (US$ Million) Table 71. Buyer Bargaining Power Company Information Table 72. Buyer Bargaining Power Business Overview Table 73. Buyer Bargaining Power Intramuscular Immune Globulin Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 74. Buyer Bargaining Power Intramuscular Immune Globulin Product Portfolio Table 75. Buyer Bargaining Power Recent Development Table 76. Competitive Rivalry Company Information Table 77. Competitive Rivalry Business Overview Table 78. Competitive Rivalry Intramuscular Immune Globulin Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 79. Competitive Rivalry Intramuscular Immune Globulin Product Portfolio Table 80. Competitive Rivalry Recent Development Table 81. Supplier Bargaining Power Company Information Table 82. Supplier Bargaining Power Business Overview Table 83. Supplier Bargaining Power Intramuscular Immune Globulin Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 84. Supplier Bargaining Power Intramuscular Immune Globulin Product Portfolio Table 85. Supplier Bargaining Power Recent Development Table 86. Threat of New Entry Company Information Table 87. Threat of New Entry Business Overview Table 88. Threat of New Entry Intramuscular Immune Globulin Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 89. Threat of New Entry Intramuscular Immune Globulin Product Portfolio Table 90. Threat of New Entry Recent Development Table 91. Threat of Substitution Company Information Table 92. Threat of Substitution Business Overview Table 93. Threat of Substitution Intramuscular Immune Globulin Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 94. Threat of Substitution Intramuscular Immune Globulin Product Portfolio Table 95. Threat of Substitution Recent Development Table 96. North America Intramuscular Immune Globulin Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 97. North America Intramuscular Immune Globulin Sales by Country (2021-2026) & (k tons) Table 98. North America Intramuscular Immune Globulin Sales Market Share by Country (2021-2026) Table 99. North America Intramuscular Immune Globulin Sales Forecast by Country (2027-2032) & (k tons) Table 100. North America Intramuscular Immune Globulin Sales Market Share Forecast by Country (2027-2032) Table 101. North America Intramuscular Immune Globulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. North America Intramuscular Immune Globulin Market Size by Country (2021-2026) & (US$ Million) Table 103. North America Intramuscular Immune Globulin Market Share by Country (2021-2026) Table 104. North America Intramuscular Immune Globulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. North America Intramuscular Immune Globulin Market Share Forecast by Country (2027-2032) Table 106. Europe Intramuscular Immune Globulin Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 107. Europe Intramuscular Immune Globulin Sales by Country (2021-2026) & (k tons) Table 108. Europe Intramuscular Immune Globulin Sales Market Share by Country (2021-2026) Table 109. Europe Intramuscular Immune Globulin Sales Forecast by Country (2027-2032) & (k tons) Table 110. Europe Intramuscular Immune Globulin Sales Market Share Forecast by Country (2027-2032) Table 111. Europe Intramuscular Immune Globulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Europe Intramuscular Immune Globulin Market Size by Country (2021-2026) & (US$ Million) Table 113. Europe Intramuscular Immune Globulin Market Share by Country (2021-2026) Table 114. Europe Intramuscular Immune Globulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Europe Intramuscular Immune Globulin Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Intramuscular Immune Globulin Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Intramuscular Immune Globulin Sales by Country (2021-2026) & (k tons) Table 118. Asia-Pacific Intramuscular Immune Globulin Sales Market Share by Country (2021-2026) Table 119. Asia-Pacific Intramuscular Immune Globulin Sales Forecast by Country (2027-2032) & (k tons) Table 120. Asia-Pacific Intramuscular Immune Globulin Sales Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Intramuscular Immune Globulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Intramuscular Immune Globulin Market Size by Country (2021-2026) & (US$ Million) Table 123. Asia-Pacific Intramuscular Immune Globulin Market Share by Country (2021-2026) Table 124. Asia-Pacific Intramuscular Immune Globulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Asia-Pacific Intramuscular Immune Globulin Market Share Forecast by Country (2027-2032) Table 126. Latin America Intramuscular Immune Globulin Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 127. Latin America Intramuscular Immune Globulin Sales by Country (2021-2026) & (k tons) Table 128. Latin America Intramuscular Immune Globulin Sales Market Share by Country (2021-2026) Table 129. Latin America Intramuscular Immune Globulin Sales Forecast by Country (2027-2032) & (k tons) Table 130. Latin America Intramuscular Immune Globulin Sales Market Share Forecast by Country (2027-2032) Table 131. Latin America Intramuscular Immune Globulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Latin America Intramuscular Immune Globulin Market Size by Country (2021-2026) & (US$ Million) Table 133. Latin America Intramuscular Immune Globulin Market Share by Country (2021-2026) Table 134. Latin America Intramuscular Immune Globulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Latin America Intramuscular Immune Globulin Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Intramuscular Immune Globulin Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Intramuscular Immune Globulin Sales by Country (2021-2026) & (k tons) Table 138. Middle East and Africa Intramuscular Immune Globulin Sales Market Share by Country (2021-2026) Table 139. Middle East and Africa Intramuscular Immune Globulin Sales Forecast by Country (2027-2032) & (k tons) Table 140. Middle East and Africa Intramuscular Immune Globulin Sales Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Intramuscular Immune Globulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Intramuscular Immune Globulin Market Size by Country (2021-2026) & (US$ Million) Table 143. Middle East and Africa Intramuscular Immune Globulin Market Share by Country (2021-2026) Table 144. Middle East and Africa Intramuscular Immune Globulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Middle East and Africa Intramuscular Immune Globulin Market Share Forecast by Country (2027-2032) Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Intramuscular Immune Globulin Distributors List Table 149. Intramuscular Immune Globulin Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Intramuscular Immune Globulin Image Figure 2. Global Intramuscular Immune Globulin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intramuscular Immune Globulin Market Size (2021-2032) & (US$ Million) Figure 4. Global Intramuscular Immune Globulin Sales (2021-2032) & (k tons) Figure 5. 10mL Vial Image Figure 6. Global 10mL Vial Sales YoY Growth (2021-2032) & (k tons) Figure 7. 2.0mL Vial Image Figure 8. Global 2.0mL Vial Sales YoY Growth (2021-2032) & (k tons) Figure 9. Global Intramuscular Immune Globulin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Intramuscular Immune Globulin Market Share by Type 2025 VS 2032 Figure 11. North America Intramuscular Immune Globulin Sales Market Share in Volume by Type in 2025 Figure 12. North America Intramuscular Immune Globulin Sales Market Share in Value by Type in 2025 Figure 13. Europe Intramuscular Immune Globulin Sales Market Share in Volume by Type in 2025 Figure 14. Europe Intramuscular Immune Globulin Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Intramuscular Immune Globulin Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Intramuscular Immune Globulin Sales Market Share in Value by Type in 2025 Figure 17. Latin America Intramuscular Immune Globulin Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Intramuscular Immune Globulin Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Intramuscular Immune Globulin Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Intramuscular Immune Globulin Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Intramuscular Immune Globulin Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hepatitis A Image Figure 24. Global Hepatitis A Sales YoY Growth (2021-2032) & (k tons) Figure 25. Measles Image Figure 26. Global Measles Sales YoY Growth (2021-2032) & (k tons) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (k tons) Figure 29. Global Intramuscular Immune Globulin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Intramuscular Immune Globulin Market Share by Application 2025 VS 2032 Figure 31. North America Intramuscular Immune Globulin Sales Market Share in Volume by Application in 2025 Figure 32. North America Intramuscular Immune Globulin Sales Market Share in Value by Application in 2025 Figure 33. Europe Intramuscular Immune Globulin Sales Market Share in Volume by Application in 2025 Figure 34. Europe Intramuscular Immune Globulin Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Intramuscular Immune Globulin Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Intramuscular Immune Globulin Sales Market Share in Value by Application in 2025 Figure 37. Latin America Intramuscular Immune Globulin Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Intramuscular Immune Globulin Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Intramuscular Immune Globulin Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Intramuscular Immune Globulin Sales Market Share in Value by Application in 2025 Figure 41. North America Intramuscular Immune Globulin Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 42. North America Intramuscular Immune Globulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Intramuscular Immune Globulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Intramuscular Immune Globulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Intramuscular Immune Globulin Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 46. Europe Intramuscular Immune Globulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Intramuscular Immune Globulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Intramuscular Immune Globulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Intramuscular Immune Globulin Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 50. Asia-Pacific Intramuscular Immune Globulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Intramuscular Immune Globulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Intramuscular Immune Globulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Intramuscular Immune Globulin Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 54. Latin America Intramuscular Immune Globulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Intramuscular Immune Globulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Intramuscular Immune Globulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Intramuscular Immune Globulin Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 58. Middle East and Africa Intramuscular Immune Globulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Intramuscular Immune Globulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Intramuscular Immune Globulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Intramuscular Immune Globulin Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Intramuscular Immune Globulin Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 10mL Vial
  • 2.0mL Vial
Applications
  • Hepatitis A
  • Measles
  • Others
Companies covered
  • Buyer Bargaining Power
  • Competitive Rivalry
  • Supplier Bargaining Power
  • Threat of New Entry
  • Threat of Substitution

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Intramuscular Immune Globulin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Intramuscular Immune Globulin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Intramuscular Immune Globulin Market by Type
  6. 1.3.1 10mL Vial
  7. 1.3.2 2.0mL Vial
  8. 1.4 Global Intramuscular Immune Globulin Market Size by Type
  9. 1.4.1 Global Intramuscular Immune Globulin Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Intramuscular Immune Globulin Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Intramuscular Immune Globulin Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Intramuscular Immune Globulin Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Intramuscular Immune Globulin Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Intramuscular Immune Globulin Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Intramuscular Immune Globulin Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Intramuscular Immune Globulin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Intramuscular Immune Globulin Industry Trends
  2. 2.2 Intramuscular Immune Globulin Industry Drivers
  3. 2.3 Intramuscular Immune Globulin Industry Opportunities and Challenges
  4. 2.4 Intramuscular Immune Globulin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Intramuscular Immune Globulin Revenue (2021-2026)
  2. 3.2 Global Top Players by Intramuscular Immune Globulin Sales (2021-2026)
  3. 3.3 Global Top Players by Intramuscular Immune Globulin Price (2021-2026)
  4. 3.4 Global Intramuscular Immune Globulin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Intramuscular Immune Globulin Major Company Production Sites & Headquarters
  6. 3.6 Global Intramuscular Immune Globulin Company, Product Type & Application
  7. 3.7 Global Intramuscular Immune Globulin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Intramuscular Immune Globulin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Intramuscular Immune Globulin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Intramuscular Immune Globulin Tier 1, Tier 2, and Tier 3
4 Intramuscular Immune Globulin Regional Status and Outlook
  1. 4.1 Global Intramuscular Immune Globulin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Intramuscular Immune Globulin Historic Market Size by Region
  3. 4.2.1 Global Intramuscular Immune Globulin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Intramuscular Immune Globulin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Intramuscular Immune Globulin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Intramuscular Immune Globulin Forecasted Market Size by Region
  7. 4.3.1 Global Intramuscular Immune Globulin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Intramuscular Immune Globulin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Intramuscular Immune Globulin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Intramuscular Immune Globulin by Application
  1. 5.1 Intramuscular Immune Globulin Market by Application
  2. 5.1.1 Hepatitis A
  3. 5.1.2 Measles
  4. 5.1.3 Others
  5. 5.2 Global Intramuscular Immune Globulin Market Size by Application
  6. 5.2.1 Global Intramuscular Immune Globulin Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Intramuscular Immune Globulin Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Intramuscular Immune Globulin Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Intramuscular Immune Globulin Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Intramuscular Immune Globulin Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Intramuscular Immune Globulin Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Intramuscular Immune Globulin Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Intramuscular Immune Globulin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Buyer Bargaining Power
  2. 6.1.1 Buyer Bargaining Power Company Information
  3. 6.1.2 Buyer Bargaining Power Business Overview
  4. 6.1.3 Buyer Bargaining Power Intramuscular Immune Globulin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Buyer Bargaining Power Intramuscular Immune Globulin Product Portfolio
  6. 6.1.5 Buyer Bargaining Power Recent Developments
  7. 6.2 Competitive Rivalry
  8. 6.2.1 Competitive Rivalry Company Information
  9. 6.2.2 Competitive Rivalry Business Overview
  10. 6.2.3 Competitive Rivalry Intramuscular Immune Globulin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Competitive Rivalry Intramuscular Immune Globulin Product Portfolio
  12. 6.2.5 Competitive Rivalry Recent Developments
  13. 6.3 Supplier Bargaining Power
  14. 6.3.1 Supplier Bargaining Power Company Information
  15. 6.3.2 Supplier Bargaining Power Business Overview
  16. 6.3.3 Supplier Bargaining Power Intramuscular Immune Globulin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Supplier Bargaining Power Intramuscular Immune Globulin Product Portfolio
  18. 6.3.5 Supplier Bargaining Power Recent Developments
  19. 6.4 Threat of New Entry
  20. 6.4.1 Threat of New Entry Company Information
  21. 6.4.2 Threat of New Entry Business Overview
  22. 6.4.3 Threat of New Entry Intramuscular Immune Globulin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Threat of New Entry Intramuscular Immune Globulin Product Portfolio
  24. 6.4.5 Threat of New Entry Recent Developments
  25. 6.5 Threat of Substitution
  26. 6.5.1 Threat of Substitution Company Information
  27. 6.5.2 Threat of Substitution Business Overview
  28. 6.5.3 Threat of Substitution Intramuscular Immune Globulin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Threat of Substitution Intramuscular Immune Globulin Product Portfolio
  30. 6.5.5 Threat of Substitution Recent Developments
7 North America by Country
  1. 7.1 North America Intramuscular Immune Globulin Sales by Country
  2. 7.1.1 North America Intramuscular Immune Globulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Intramuscular Immune Globulin Sales by Country (2021-2026)
  4. 7.1.3 North America Intramuscular Immune Globulin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Intramuscular Immune Globulin Market Size by Country
  6. 7.2.1 North America Intramuscular Immune Globulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Intramuscular Immune Globulin Market Size by Country (2021-2026)
  8. 7.2.3 North America Intramuscular Immune Globulin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Intramuscular Immune Globulin Sales by Country
  2. 8.1.1 Europe Intramuscular Immune Globulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Intramuscular Immune Globulin Sales by Country (2021-2026)
  4. 8.1.3 Europe Intramuscular Immune Globulin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Intramuscular Immune Globulin Market Size by Country
  6. 8.2.1 Europe Intramuscular Immune Globulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Intramuscular Immune Globulin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Intramuscular Immune Globulin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Intramuscular Immune Globulin Sales by Country
  2. 9.1.1 Asia-Pacific Intramuscular Immune Globulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Intramuscular Immune Globulin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Intramuscular Immune Globulin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Intramuscular Immune Globulin Market Size by Country
  6. 9.2.1 Asia-Pacific Intramuscular Immune Globulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Intramuscular Immune Globulin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Intramuscular Immune Globulin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Intramuscular Immune Globulin Sales by Country
  2. 10.1.1 South America Intramuscular Immune Globulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Intramuscular Immune Globulin Sales by Country (2021-2026)
  4. 10.1.3 South America Intramuscular Immune Globulin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Intramuscular Immune Globulin Market Size by Country
  6. 10.2.1 South America Intramuscular Immune Globulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Intramuscular Immune Globulin Market Size by Country (2021-2026)
  8. 10.2.3 South America Intramuscular Immune Globulin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Intramuscular Immune Globulin Sales by Country
  2. 11.1.1 Middle East and Africa Intramuscular Immune Globulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Intramuscular Immune Globulin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Intramuscular Immune Globulin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Intramuscular Immune Globulin Market Size by Country
  6. 11.2.1 Middle East and Africa Intramuscular Immune Globulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Intramuscular Immune Globulin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Intramuscular Immune Globulin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Intramuscular Immune Globulin Value Chain Analysis
  2. 12.1.1 Intramuscular Immune Globulin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Intramuscular Immune Globulin Production Mode & Process
  7. 12.2 Intramuscular Immune Globulin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Intramuscular Immune Globulin Distributors
  10. 12.2.3 Intramuscular Immune Globulin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst